References
- Bray F , FerlayJ, SoerjomataramI, SiegelRL, TorreLA, JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
- Sanli O , DobruchJ, KnowlesMAet al. Bladder cancer. Nat. Rev. Dis. Primers3, 17022 (2017).
- Berdik C . Unlocking bladder cancer. Nature551(7679), S34–S35 (2017).
- Grayson M . Bladder cancer. Nature551(7679), S33 (2017).
- Ler LD , GhoshS, ChaiXet al. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci. Transl. Med.9(378), doi: 10.1126/scitranslmed.aai831 (2017).
- Prasad SM , DecastroGJ, SteinbergGD, Medscape. Urothelial carcinoma of the bladder: definition, treatment and future efforts. Nat. Rev. Urol.8(11), 631–642 (2011).
- Svatek RS , HollenbeckBK, HolmangSet al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur. Urol.66(2), 253–262 (2014).
- National Institute for Health and Care Excellence (NICE) Bladder cancer: diagnosis and management of bladder cancer: (c) NICE (2015) bladder cancer: diagnosis and management of bladder cancer. BJU Int. 120(6), 755–765 (2017).
- Asano K , MikiJ, MaedaS, NaruokaT, TakahashiH, OishiY. Clinical studies on inverted papilloma of the urinary tract: report of 48 cases and review of the literature. J Urol.170(4 Pt 1), 1209–1212 (2003).
- Picozzi S , CasellatoS, BozziniGet al. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients. Urol. Oncol.31(8), 1584–1590 (2013).
- Takeuchi M , SasaguriK, NaikiTet al. MRI findings of inverted urothelial papilloma of the bladder. AJR Am. J. Roentgenol.205(2), 311–316 (2015).
- Kuznetsov HS , MarshT, MarkensBAet al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov.2(12), 1150–1165 (2012).
- Mcallister SS , WeinbergRA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol.16(8), 717–727 (2014).
- Menter DG , TuckerSC, KopetzS, SoodAK, CrissmanJD, HonnKV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev.33(1), 231–269 (2014).
- Menter DG , KopetzS, HawkEet al. Platelet ‘first responders’ in wound response, cancer, and metastasis. Cancer Metastasis Rev.36(2), 199–213 (2017).
- Sol N , WurdingerT. Platelet RNA signatures for the detection of cancer. Cancer Metastasis Rev.36(2), 263–272 (2017).
- Dincel O , BayraktarC. Evaluation of platelet indices as a useful marker in papillary thyroid carcinoma. Bratislavske Lekarske Listy118(3), 153–155 (2017).
- Zhu X , CaoY, LuPet al. Evaluation of platelet indices as diagnostic biomarkers for colorectal cancer. Sci. Rep.8(1), 11814 (2018).
- Gasparyan AY , AyvazyanL, MikhailidisDP, KitasGD. Mean platelet volume: a link between thrombosis and inflammation?Curr. Pharm. Des.17(1), 47–58 (2011).
- Wang X , CuiMM, XuYet al. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer. Oncotarget8(40), 68115–68122 (2017).
- Farah R , SamraN. Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke. J. Clin. Lab. Anal.32(1), doi: 10.1002/jcla.22189 (2018).
- Bath PM , ButterworthRJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul. Fibrinolysis7(2), 157–161 (1996).
- Zhang X , CuiMM, FuSet al. Platelet distribution width correlates with prognosis of gastric cancer. Oncotarget8(12), 20213–20219 (2017).
- Ergelen M , UyarelH. Plateletcrit: a novel prognostic marker for acute coronary syndrome. Int. J. Cardiol.177(1), 161 (2014).
- Oncel M , KiyiciA, OncelM, SunamGS, SahinE, AdamB. Evaluation of platelet indices in lung cancer patients. Asian Pac. J. Cancer Prev.16(17), 7599–7602 (2015).
- Gu M , ZhaiZ, HuangLet al. Pre-treatment mean platelet volume associates with worse clinicopathologic features and prognosis of patients with invasive breast cancer. Breast Cancer23(5), 752–760 (2016).
- Ma C , LuB, DiaoCet al. Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer. OncoTargets Ther.9, 4917–4922 (2016).
- Semple JW , ItalianoJEJr, FreedmanJ. Platelets and the immune continuum. Nat. Rev. Immunol.11(4), 264–274 (2011).
- Santimone I , DiCastelnuovo A, DeCurtis Aet al. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica96(8), 1180–1188 (2011).
- Cheng S , HanF, WangYet al. The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. BMC Gastroenterol.17(1), 163 (2017).
- Takeuchi H , AbeM, TakumiYet al. The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer. PLoS ONE12(12), e0189166 (2017).
- Chandrashekar V , TarigopulaA. Can platelet distribution width be used to predict the possibility of chronic myeloproliferative neoplasms?Lab. Med.doi:10.1093/labmed/lmy061 (2018) ( Epub ahead of print).
- Huang Y , CuiMM, HuangYXet al. Preoperative platelet distribution width predicts breast cancer survival. Cancer Biomarkers23(2), 205–211 (2018).
- Wen W , WuP, LiJ, WangH, SunJ, ChenH. Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. J. Translational Med.16(1), 261 (2018).